21.27MMarket Cap-626P/E (TTM)
2.760High2.410Low12.39KVolume2.450Open2.520Pre Close30.95KTurnover0.23%Turnover RatioLossP/E (Static)8.12MShares4.55052wk High0.78P/B13.92MFloat Cap2.41052wk Low--Dividend TTM5.31MShs Float36.720Historical High--Div YieldTTM13.89%Amplitude2.410Historical Low2.498Avg Price1Lot Size
Lumos Pharma Stock Forum
News
Update
Seminar Started
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
Hehehe
News!
Met All Primary and Secondary Endpoints
Phase 2 Data Provide Supportive Evidence to Advance Oral LUM-201 to Phase 3
•OraGrowtH210 Results Show LUM-201 Dose of 1.6 mg/kg Achieves Annualized Height Velocities (AHV) of 8.2 cm/yr at 6 Months and 8.0 cm/yr at 12 Months, Comparable to Growth Rates for Moderate PGHD Population
•Delta at 6 and 12-month AHV Between Optima...
No comment yet